Advances of cancer-associated fibroblasts in liver cancer
Abstract Liver cancer is one of the most common malignant tumors worldwide, it is ranked sixth in incidence and fourth in mortality. According to the distinct origin of malignant tumor cells, liver cancer is mainly divided into hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). Since most...
Saved in:
Main Authors: | Hao Peng (Author), Erwei Zhu (Author), Yewei Zhang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic-suppressed cancer-associated fibroblasts limit the immune environment and survival in colorectal cancer with liver metastasis
by: Chenghao Wu, et al.
Published: (2023) -
Biomarkers for cancer-associated fibroblasts
by: Chencheng Han, et al.
Published: (2020) -
Cancer-associated fibroblasts mediate resistance to anti-EGFR therapies in cancer
by: Shuang Dai, et al.
Published: (2024) -
Advances in targeting cancer-associated fibroblasts through single-cell spatial transcriptomic sequencing
by: Pin Lyu, et al.
Published: (2024) -
RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma
by: Hao Peng, et al.
Published: (2022)